UpdatesPress Release

Anlon Healthcare reports strong FY26 results with revenue up 43% to ₹172.22 Cr.

Anlon Healthcare LimitedAHCL · Filed with the exchange

Strategic acquisitions of Bizotic Lifescience and Apiqo Organics strengthen its manufacturing and backward integration capabilities.

Read the original filing(PDF)

No comments yet. Be the first.

More from Anlon Healthcare Limited

All announcements